Related Experiment Videos
Simian immunodeficiency virus displays complex patterns of RNA splicing
G A Viglianti1, P L Sharma, J I Mullins
1Department of Cancer Biology, Harvard University School of Public Health, Boston, Massachusetts 02115.
Journal of Virology
|September 1, 1990
Summary
Simian immunodeficiency virus (SIV) gene expression is complex due to alternative RNA splicing. This process generates diverse messenger RNAs (mRNAs), potentially influencing the regulation of viral proteins.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Human and simian immunodeficiency viruses (HIV/SIV) encode regulatory proteins crucial for viral replication.
- Understanding the precise mechanisms of SIV gene expression, particularly RNA splicing, is vital for comprehending viral pathogenesis.
Purpose of the Study:
- To investigate the role of alternative pre-messenger RNA (pre-mRNA) splicing in regulating simian immunodeficiency virus (SIV) gene expression.
- To identify diverse messenger RNA (mRNA) transcripts arising from SIV infection and their implications for protein expression.
Main Methods:
- Utilized the polymerase chain reaction (PCR) to amplify and clone complementary DNAs (cDNAs) from SIV-infected cells.
- Analyzed a wide array of SIV mRNAs to identify alternative splice acceptor sites and intron-exon boundaries.
Main Results:
- Identified mRNAs utilizing distinct splice acceptor sites for regulatory genes like tat, rev, vpr, nef, vif, and vpx.
- Observed alternative splicing events for rev and env mRNAs, as well as multiple splice variants for tat and rev proteins.
- Found that 10-20% of SIV mRNAs spliced an intron from their 5' untranslated regions, with sequences influencing the tat-responsive TAR element.
Conclusions:
- Alternative pre-mRNA splicing significantly increases the complexity of SIV gene expression.
- This splicing diversity may impact multiple levels of SIV gene regulation and protein production.
- Findings contribute to a deeper understanding of SIV molecular biology and potential therapeutic targets.